Cognition Therapeutics Inc (CGTX) stock saw a modest uptick, ending the day at $0.65 which represents a slight increase of $0.04 or 6.56% from the prior close of $0.61. The stock opened at $0.61 and ...

Fintel reports that on December 19, 2024, B. Riley Securities upgraded their outlook for Cognition Therapeutics ...

On Friday, Cognition Therapeutics Inc (CGTX) stock saw a modest uptick, ending the day at $0.63 which represents no change from the prior close of of $0.63. The stock opened at $0.64 and touched a low ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

B. Riley analyst Mayank Mamtani upgraded Cognition Therapeutics (CGTX) to Buy from Neutral with a price target of $1.50, up ...

On Thursday, H.C. Wainwright adjusted its stock price target for Cognition Therapeutics (NASDAQ:CGTX), a company focused on developing drugs for neurodegenerative disorders. The firm increased the ...

Build financial models with decades of earnings stats, ratios, and valuation data — all exportable — to power your trade ideas.

We currently have no CGTX Stock Split History on this stock.

After hours: December 20 at 7:59:39 p.m. EST ...